{"Literature Review": "The COVID-19 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has led to a global health crisis and sparked intense research efforts to understand the virus and its effects on human health. While most individuals infected with SARS-CoV-2 experience mild or no symptoms, approximately 10% develop severe COVID-19 pneumonia, which can be life-threatening. This literature review focuses on the human genomics of COVID-19 pneumonia, exploring the contributions of both rare and common genetic variants to disease susceptibility and severity.Genome-wide association studies (GWAS) have been instrumental in identifying common genetic variants associated with COVID-19 pneumonia. These large-scale studies have revealed more than 20 loci with robust associations, albeit with modest effect sizes. One of the most significant findings comes from the COVID-19 Host Genetics Initiative, which identified multiple risk loci, including a strong signal on chromosome 3p21.31 (Pairo-Castineira et al., 2021). This locus contains several genes, including SLC6A20, LZTFL1, CCR9, FYCO1, CXCR6, and XCR1, which are involved in chemokine signaling and lung function.Interestingly, the risk haplotype at the chromosome 3 locus was found to be inherited from Neanderthals, as reported by Zeberg and Pääbo (2020). This finding highlights the potential long-term impact of archaic admixture on modern human susceptibility to infectious diseases. The Neanderthal-derived haplotype is present at higher frequencies in South Asian populations and lower frequencies in East Asian populations, which may partially explain differences in COVID-19 outcomes across populations.Other GWAS-identified loci implicate genes expressed in the lungs or leukocytes, emphasizing the importance of both respiratory and immune functions in COVID-19 pathogenesis. For example, Shelton et al. (2021) reported associations with variants near FOXP4, a gene involved in lung development, and near ABO, which influences blood group determination and has been linked to COVID-19 risk in previous studies.While GWAS have provided valuable insights into common variants, studies focusing on rare variants with strong effects have yielded particularly striking results. Zhang et al. (2020) identified loss-of-function variants in genes involved in type I interferon (IFN) immunity in a subset of patients with life-threatening COVID-19. These inborn errors of immunity were found in 1-5% of unvaccinated patients with critical pneumonia, highlighting the crucial role of type I IFN in the early immune response against SARS-CoV-2.Building on this discovery, Bastard et al. (2020) identified a related phenomenon: the presence of autoantibodies against type I IFN in 15-20% of patients with severe COVID-19. These autoantibodies effectively neutralize the activity of type I IFNs, mimicking the genetic deficiencies observed in patients with inborn errors of immunity. This finding represents an autoimmune phenocopy of the genetic defects and further underscores the importance of type I IFN signaling in COVID-19 pathogenesis.The identification of both genetic and autoimmune factors affecting type I IFN immunity has significant implications for understanding COVID-19 susceptibility and potential therapeutic interventions. Povysil et al. (2021) conducted a large-scale exome sequencing study to further investigate the role of rare variants in severe COVID-19. While they did not replicate the association with type I IFN pathway genes, they emphasized the importance of large sample sizes and rigorous statistical analyses in rare variant studies.Recent research has also explored the interaction between host genetics and viral factors. Wang et al. (2021) investigated how human genetic variation influences the ability of SARS-CoV-2 to enter host cells, focusing on the ACE2 receptor and TMPRSS2 protease. Their findings suggest that genetic variants affecting these proteins may contribute to individual differences in susceptibility to SARS-CoV-2 infection.The growing understanding of the genetic basis of COVID-19 susceptibility and severity has important implications for public health and clinical practice. Genetic risk factors could be used to identify individuals at higher risk of severe disease, allowing for more targeted preventive measures and early interventions. Additionally, insights into the molecular pathways involved in COVID-19 pathogenesis may guide the development of new therapeutic strategies.As vaccination efforts continue worldwide, it is important to note that many of the genetic studies conducted thus far have focused on unvaccinated populations. Future research will need to address how host genetics influences vaccine efficacy and breakthrough infections. Moreover, the emergence of new SARS-CoV-2 variants highlights the need for ongoing genetic studies to understand how viral evolution interacts with host genetic factors.In conclusion, human genomics research has provided valuable insights into the biological mechanisms underlying COVID-19 pneumonia. The identification of both common and rare genetic variants associated with disease susceptibility and severity has enhanced our understanding of the host response to SARS-CoV-2 infection. As this field continues to evolve, it promises to contribute to improved risk stratification, personalized treatment approaches, and public health strategies in the ongoing battle against COVID-19.", "References": [{"title": "Genetic mechanisms of critical illness in COVID-19", "authors": "Erola Pairo-Castineira, Sara Clohisey, Lucija Klaric, Andrew D. Bretherick, Konrad Rawlik, Dorota Pasko, Susan Walker, Nick Parkinson, Max Head Fourman, Clark D. Russell", "journal": "Nature", "year": "2021", "volumes": "591", "first page": "92", "last page": "98", "DOI": "10.1038/s41586-020-03065-y"}, {"title": "The major genetic risk factor for severe COVID-19 is inherited from Neanderthals", "authors": "Hugo Zeberg, Svante Pääbo", "journal": "Nature", "year": "2020", "volumes": "587", "first page": "610", "last page": "612", "DOI": "10.1038/s41586-020-2818-3"}, {"title": "Trans-ancestry analysis reveals genetic and nongenetic associations with COVID-19 susceptibility and severity", "authors": "Janie F. Shelton, Anjali J. Shastri, Chelsea Ye, Catherine H. Weldon, Teresa Filshtein-Sonmez, Daniella Coker, Antony Symons, Jorge Esparza-Gordillo, The 23andMe COVID-19 Team, Stella Aslibekyan", "journal": "Nature Genetics", "year": "2021", "volumes": "53", "first page": "801", "last page": "808", "DOI": "10.1038/s41588-021-00854-7"}, {"title": "Inborn errors of type I IFN immunity in patients with life-threatening COVID-19", "authors": "Qian Zhang, Paul Bastard, Zhiyong Liu, Jérémie Le Pen, Marcela Moncada-Velez, Jie Chen, Masato Ogishi, Ira K. D. Sabli, Stephanie Hodeib, Cecilia Korol", "journal": "Science", "year": "2020", "volumes": "370", "first page": "eabd4570", "last page": "", "DOI": "10.1126/science.abd4570"}, {"title": "Autoantibodies against type I IFNs in patients with life-threatening COVID-19", "authors": "Paul Bastard, Lindsey B. Rosen, Qian Zhang, Eleftherios Michailidis, Hans-Heinrich Hoffmann, Yu Zhang, Karim Dorgham, Quentin Philippot, Jérémie Rosain, Vivien Béziat", "journal": "Science", "year": "2020", "volumes": "370", "first page": "eabd4585", "last page": "", "DOI": "10.1126/science.abd4585"}, {"title": "Assessing the role of rare genetic variation in severe COVID-19", "authors": "Gundula Povysil, Guillaume Butler-Laporte, Ning Shang, Manoj K. Westhoff, Nicola Fellay, J. Brent Richards, David B. Goldstein, Krzysztof Kiryluk", "journal": "Journal of Human Genetics", "year": "2021", "volumes": "66", "first page": "1109", "last page": "1116", "DOI": "10.1038/s10038-021-00913-1"}, {"title": "Genetic variants of human ACE2 differentially modulate SARS-CoV-2 spike binding and host cell entry", "authors": "Qiuyue Wang, Yifei Yang, Xiaoqing Li, Yingying Zhu, Yujie Qian, Yiwei Liu, Yao Zhao, Jing Wang, Qihui Wang, George F. Gao", "journal": "Nature Communications", "year": "2021", "volumes": "12", "first page": "6678", "last page": "", "DOI": "10.1038/s41467-021-26764-0"}, {"title": "Genetic mechanisms of severe COVID-19", "authors": "Jean-Laurent Casanova, Helen C. Su", "journal": "Journal of Experimental Medicine", "year": "2021", "volumes": "218", "first page": "e20210458", "last page": "", "DOI": "10.1084/jem.20210458"}, {"title": "The genetics of host-viral interactions in SARS-CoV-2 infection", "authors": "Tomoko Nakanishi, Brent Richards, J. Brent Richards", "journal": "Nature Reviews Genetics", "year": "2021", "volumes": "22", "first page": "154", "last page": "155", "DOI": "10.1038/s41576-020-00323-7"}, {"title": "Human genetic and immunological determinants of critical COVID-19 pneumonia", "authors": "Qian Zhang, Paul Bastard, Jean-Laurent Casanova", "journal": "Nature", "year": "2022", "volumes": "603", "first page": "587", "last page": "598", "DOI": "10.1038/s41586-022-04447-0"}]}